Effect of Dalfampridine in Treatment of Spinal Cord Injury
Phase 3
Recruiting
- Conditions
- T09.3Thoracic Spinal Cord Injury.Injury of spinal cord, level unspecified
- Registration Number
- IRCT20231019059767N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
All Patients with Traumatic Thoracic Spinal Cord Injury
Patients with ASIA Scale C or D
Patients without any Contraindications for Dalfampridine Prescription
Patients having 18 to 70 Years of Age
Patients who have GCS 15
Exclusion Criteria
Any History of Seizure in Patient
Pregnancy
GFR Lower than 50 ml/min
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25-Foot Walk Test. Timepoint: At the beginning of study (Before Treatment), 30, and 60 days after initiation of treatment. Method of measurement: Chronometer watch.
- Secondary Outcome Measures
Name Time Method